Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

51.250
-1.400-2.66%
Volume:43.80M
Turnover:2.20B
Market Cap:211.00B
PE:37.65
High:51.450
Open:51.050
Low:49.020
Close:52.650
52wk High:58.000
52wk Low:28.480
Shares:4.12B
HK Float Shares:4.12B
Volume Ratio:0.93
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.361
ROE:11.38%
ROA:7.60%
PB:3.74
PE(LYR):37.65
PS:7.62

Loading ...

WuXi Biologics Makes Forbes China ESG 50 List for 2026

Reuters
·
Sep 16

Movement Alert|WUXI BIO Rises 3.21% in Regular Trading, CXO Sector Extends Mid-Year Earnings Rally

Market Focus
·
Sep 16

Wuxi Biologics (Cayman) Stock Advances 4.6% in Hong Kong

Dow Jones
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

Movement Alert|WUXI BIO Rises 3.06% in Regular Trading, CXO Sector Rallies on Valuation Recovery and Strong Fundamentals

Market Focus
·
Sep 14

Hong Kong Market Update | CRO Stocks Lead Gains as Interim Results Reinforce Sector Momentum, Multiple Firms Lift Guidance

Stock News
·
Sep 14

Goldman Sachs Sees Clear Recovery in China's CRO/CDMO Sector, Favorable on WuXi-Linked Stocks

Stock News
·
Sep 14

Wuxi Biologics (Cayman) Stock Slips 2.7% in Hong Kong

Dow Jones
·
Sep 10

Movement Alert|WUXI BIO Falls 3.07% in Regular Trading, Trading at 47.44 HKD

Market Focus
·
Sep 10

WuXi Biologics Issues 1.20 Million New Shares; 39.82 Million Shares Await Cancellation

Bulletin Express
·
Sep 09

WuXi Biologics Files HKEX Next-Day Disclosure, Share Capital Rises by 1.2 Million Shares

Reuters
·
Sep 09

Transcenta Licenses HiCB Bioprocessing Technology to WuXi Biologics for RMB 10 Million Upfront

Reuters
·
Sep 09

Transcenta Holding - to Receive RMB 10 Mln Upfront Payment and Milestone Payments

THOMSON REUTERS
·
Sep 09

Transcenta Holding - Grants WuXi Biologics Non-Exclusive License to Hicb Platform and Excelpro Cell Culture Media

THOMSON REUTERS
·
Sep 09

Wuxi Biologics (Cayman) Stock Climbs 1.7% in Hong Kong

Dow Jones
·
Sep 08

WuXi Biologics Files HKEX Next-Day Disclosure Return, Issues 1,804,090 New Shares

Reuters
·
Sep 07

Wuxi Biologics (Cayman) Stock Slides 1.4% in Hong Kong

Dow Jones
·
Sep 07

WuXi Bio Issues 3.2 Million Shares Following Option Exercise

Stock News
·
Sep 04

Wall Street Cues, Easing Bond Yields Boost Asian Stock Markets

MT Newswires Live
·
Sep 04

Movement Alert|WUXI BIO Falls 3.12% in Regular Trading, Post-Earnings Profit-Taking and CXO Sector Pullback Weigh on Shares

Market Focus
·
Sep 04